Martine A. Rothblatt is CEO & Chairman at UNITED THERAPEUTICS CORP (UTHR). They have made 265 open-market trades across 1 company since 2005, most recently 2026-10-15.
CIK 0001106578
5 open-market purchases totalling $15.9M since 2009, against 260 sales. Across 5 scored buys the stock is up 0.8% at ninety days, and 0.6 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| UTHR | 324,443 | $173.0M |
| BETA | 8,213 | $148K |
| Total | $173.2M |
Shares reported on the most recent Form 4, priced at the 2026-10-16 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -11.9% | +0.8% | +0.8% |
| Alpha | -6.1% | +0.6% | +0.6% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UTHR | SELL · 10b5-1 | 2026-10-15 | 2026-10-16 | $546.65 | $5.2M | — | — | — |
| UTHR | SELL · 10b5-1 | 2026-10-14 | 2026-10-15 | $539.99 | $5.1M | — | — | — |
| UTHR | SELL · 10b5-1 | 2026-10-13 | 2026-10-14 | $545.52 | $5.2M | — | — | — |
| UTHR | SELL · 10b5-1 | 2026-10-12 | 2026-10-13 | $550.70 | $5.2M | — | — | — |
| UTHR | SELL · 10b5-1 | 2026-10-09 | 2026-10-13 | $544.94 | $5.2M | — | — | — |
| UTHR | SELL · 10b5-1 | 2026-10-08 | 2026-10-09 | $534.31 | $5.1M | — | — | — |
| UTHR | SELL · 10b5-1 | 2026-10-07 | 2026-10-08 | $548.95 | $5.2M | — | — | — |
| UTHR | SELL · 10b5-1 | 2026-10-06 | 2026-10-07 | $538.67 | $5.1M | — | — | — |
| UTHR | SELL · 10b5-1 | 2026-10-05 | 2026-10-06 | $541.64 | $5.1M | -1.9% | — | — |
| UTHR | SELL · 10b5-1 | 2026-10-02 | 2026-10-05 | $549.37 | $5.2M | +1.2% | — | — |
| UTHR | SELL · 10b5-1 | 2026-10-01 | 2026-10-02 | $576.47 | $5.5M | +0.2% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-30 | 2026-10-01 | $517.97 | $3.9M | -4.6% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-30 | 2026-10-01 | $550.22 | $1.1M | -4.6% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-29 | 2026-09-30 | $477.42 | $4.5M | -1.6% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-28 | 2026-09-29 | $480.85 | $4.6M | +13.7% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-25 | 2026-09-28 | $476.17 | $4.5M | +9.4% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-24 | 2026-09-25 | $473.55 | $4.5M | +15.3% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-23 | 2026-09-24 | $491.57 | $4.7M | +14.6% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-22 | 2026-09-23 | $494.83 | $4.7M | +13.3% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-21 | 2026-09-22 | $494.55 | $4.7M | +8.9% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-18 | 2026-09-21 | $494.79 | $4.7M | +15.4% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-17 | 2026-09-18 | $496.06 | $4.7M | +9.0% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-16 | 2026-09-17 | $501.39 | $4.8M | -3.3% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-15 | 2026-09-16 | $501.59 | $4.8M | -2.7% | +6.8% | — |
| UTHR | SELL · 10b5-1 | 2026-09-14 | 2026-09-15 | $504.12 | $4.8M | -5.6% | +7.6% | — |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.